Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.03.2022 | Case report

Antineoplastics/pegaldesleukin/vitamins

Hypothyroidism and false high levels of thyroid stimulating hormone due to interference in thyroid function tests: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ridgway FN, et al. Biotin-induced thyroid stimulating hormone aberrations in the setting of immunotherapy. Journal of Oncology Pharmacy Practice 27: 2057-2060, No. 8, Dec 2021. Available from: URL: http://opp.sagepub.com/archive/ Ridgway FN, et al. Biotin-induced thyroid stimulating hormone aberrations in the setting of immunotherapy. Journal of Oncology Pharmacy Practice 27: 2057-2060, No. 8, Dec 2021. Available from: URL: http://​opp.​sagepub.​com/​archive/​
Metadaten
Titel
Antineoplastics/pegaldesleukin/vitamins
Hypothyroidism and false high levels of thyroid stimulating hormone due to interference in thyroid function tests: case report
Publikationsdatum
01.03.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-11295-x

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Gilteritinib

Case report

Ipilimumab

Case report

Gentamicin